Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Woonyoung Choi

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
European Urology|November 28, 2017
Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65Woonyoung Choi, David McConkey
Journal of the National Cancer Institute|January 18, 2018
Subtyping Bladder Cancers: Biology vs BioinformaticsDavid J McConkey, Woonyoung Choi
Frontiers in Oncology|April 15, 2021
Editorial: Recent Advances in Diagnosis and Management of Urothelial CarcinomaJa Hyeon Ku, Woonyoung Choi
European Urology|October 28, 2018
ERCC2 Mutation: The Marker for Chemosensitivity in Primary and Secondary Muscle-invasive Bladder CancersWoonyoung Choi, David J McConkey
Current Oncology Reports|August 22, 2018
Molecular Subtypes of Bladder CancerDavid J McConkey, Woonyoung Choi
European Urology|September 10, 2014
Reply to Mattias Aine, Fredrik Liedberg, Gottfrid Sjödahl, and Mattias Höglund's Letter to the Editor re: David J. McConkey, Woonyoung Choi, Colin P.N. Dinney. New insights into subtypes of invasive bladder cancer: considerations of the clinician. Eur Urol 2014;66:609-10David McConkey, Woonyoung Choi, Colin Dinney
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma linesYasmine Haddad, Woonyoung Choi, David J McConkey
Technology in Cancer Research & Treatment|March 11, 2003
Understanding cancer through proteomicsWoonyoung Choi, Sonya W Song, Wei Zhang
Current Opinion in Urology|July 29, 2015
Genetic subtypes of invasive bladder cancerDavid J McConkey, Woonyoung Choi, Colin P N Dinney
European Urology|June 1, 2014
New insights into subtypes of invasive bladder cancer: considerations of the clinicianDavid J McConkey, Woonyoung Choi, Colin P N Dinney
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
European Urology|November 28, 2017
Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65Woonyoung Choi, David McConkey
Journal of the National Cancer Institute|January 18, 2018
Subtyping Bladder Cancers: Biology vs BioinformaticsDavid J McConkey, Woonyoung Choi
Frontiers in Oncology|April 15, 2021
Editorial: Recent Advances in Diagnosis and Management of Urothelial CarcinomaJa Hyeon Ku, Woonyoung Choi
European Urology|October 28, 2018
ERCC2 Mutation: The Marker for Chemosensitivity in Primary and Secondary Muscle-invasive Bladder CancersWoonyoung Choi, David J McConkey
Current Oncology Reports|August 22, 2018
Molecular Subtypes of Bladder CancerDavid J McConkey, Woonyoung Choi
European Urology|September 10, 2014
Reply to Mattias Aine, Fredrik Liedberg, Gottfrid Sjödahl, and Mattias Höglund's Letter to the Editor re: David J. McConkey, Woonyoung Choi, Colin P.N. Dinney. New insights into subtypes of invasive bladder cancer: considerations of the clinician. Eur Urol 2014;66:609-10David McConkey, Woonyoung Choi, Colin Dinney
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma linesYasmine Haddad, Woonyoung Choi, David J McConkey
Technology in Cancer Research & Treatment|March 11, 2003
Understanding cancer through proteomicsWoonyoung Choi, Sonya W Song, Wei Zhang
Current Opinion in Urology|July 29, 2015
Genetic subtypes of invasive bladder cancerDavid J McConkey, Woonyoung Choi, Colin P N Dinney
European Urology|June 1, 2014
New insights into subtypes of invasive bladder cancer: considerations of the clinicianDavid J McConkey, Woonyoung Choi, Colin P N Dinney
Pageof 9